Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Transocean
RIG
$6.38B
| $16.4M | 0.01% |
4,337,286
-349,572
| -7% | -$1.27M |
|
|
LGF.B
1727
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $16.4M | 0.01% |
1,264,244
+22,566
| +2% | +$297K |
|
1728
Ingles Markets
IMKTA
$1.68B
| $16.4M | 0.01% |
248,711
+7,043
| +3% | +$447K |
|
1729
Iovance Biotherapeutics
IOVA
$2.95B
| $16.4M | 0.01% |
665,896
-89,520
| -12% | -$2.11M |
|
1730
Triumph Financial Inc
TFIN
$1.87B
| $16.4M | 0.01% |
163,942
+5,664
| +4% | +$454K |
|
|
ONEM
1731
DELISTED
1Life Healthcare
ONEM
| $16.3M | 0.01% |
807,306
-12,313
| -2% | -$317K |
|
1732
Nektar Therapeutics
NKTR
$2.56B
| $16.3M | 0.01% |
60,505
+1,087
| +2% | +$261K |
|
|
FLNA
1733
Filana Therapeutics
FLNA
$45.9M
| $16.3M | 0.01% |
262,291
+167,214
| +176% | +$14M |
|
1734
ICF International
ICFI
$1.6B
| $16.3M | 0.01% |
182,031
+4,452
| +3% | +$405K |
|
1735
Cal-Maine
CALM
$3.87B
| $16.2M | 0.01% |
448,882
+31,700
| +8% | +$1.13M |
|
|
LAZR
1736
DELISTED
Luminar Technologies
LAZR
| $16.2M | 0.01% |
69,238
+12,631
| +22% | +$3.34M |
|
|
ACCD
1737
DELISTED
Accolade Inc
ACCD
| $16.2M | 0.01% |
384,211
+199,456
| +108% | +$9.37M |
|
|
CSGS
1738
DELISTED
CSG Systems International
CSGS
| $16.2M | 0.01% |
335,750
+11,316
| +3% | +$529K |
|
1739
ePlus
PLUS
$2.32B
| $16.1M | 0.01% |
314,040
+10,114
| +3% | +$500K |
|
1740
DNOW Inc
DNOW
$2.95B
| $16.1M | 0.01% |
2,102,992
+189,220
| +10% | +$1.55M |
|
1741
Revolve Group
RVLV
$1.72B
| $16M | 0.01% |
259,435
+169,908
| +190% | +$11.1M |
|
|
RWT
1742
Redwood Trust
RWT
$599M
| $16M | 0.01% |
1,238,402
+8,370
| +0.7% | +$102K |
|
1743
OSI Systems
OSIS
$3.76B
| $15.9M | 0.01% |
168,052
+4,333
| +3% | +$422K |
|
|
WWE
1744
DELISTED
World Wrestling Entertainment
WWE
| $15.9M | 0.01% |
282,990
-20,736
| -7% | -$1.08M |
|
1745
Patterson-UTI
PTEN
$4.15B
| $15.9M | 0.01% |
1,768,670
-39,970
| -2% | -$324K |
|
1746
Eagle Bancorp
EGBN
$877M
| $15.9M | 0.01% |
276,697
+32
| +0% | +$1.79K |
|
|
WLL
1747
DELISTED
Whiting Petroleum Corporation
WLL
| $15.9M | 0.01% |
272,192
+2,196
| +0.8% | +$109K |
|
|
NXRT
1748
NexPoint Residential Trust
NXRT
$636M
| $15.9M | 0.01% |
256,802
+4,659
| +2% | +$283K |
|
1749
Unisys
UIS
$210M
| $15.9M | 0.01% |
631,253
+2,399
| +0.4% | +$56.7K |
|
|
AAMI
1750
Acadian Asset Management
AAMI
$3.31B
| $15.9M | 0.01% |
607,199
+19,140
| +3% | +$493K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.